TrialReader


Curarisation and Intubation Conditions During Videolaryngoscopy With Glidescope Titanium

NCT02404142 — Phase 4, Completed, 64 participants, CHU de Reims

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT02404142, acronym GICAC
StatusCompleted
PhasePhase 4
Study typeInterventional; randomized, parallel, masking: triple, treatment
Enrollment64 (Actual)
SponsorCHU de Reims (Other); collaborators: Verathon
ConditionsTracheal Intubation
InterventionsCurare (Atracurium), saline isotonic solution (Drug)
Datesstart 2015-02-20, primary completion 2016-04-05, completion 2016-08-05, first posted 2015-03-31, last updated 2018-01-09
Locations1 site in France

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Tracheal Intubation All trials of Curare (Atracurium) All trials of saline isotonic solution

-Summary

In this prospective, randomized study, the investigators assess the intubation conditions during videolaryngoscopy with Glidescope Titanium whether patients receive (curare (Atracurium) group) or no (control group) within elective surgery patients with no difficult intubation prediction

Expand all sections  ·  Collapse all

+Detailed description

In this prospective, randomized study, the investigators assess the intubation conditions during videolaryngoscopy with Glidescope Titanium whether patients receive (curare (Atracurium)group) or no (control group) within elective surgery patients with no difficult intubation prediction. The IDS score assessed by an anesthesiologist from the video-recording is the primary outcome. All general anesthesias are standardized using Target Control Infusion of propofol and sufentanil. The investigators also compare IDS scores as assessed by intubators, time for tracheal intubation, and laryngeal morbidity in both groups.

+Arms and interventions

ArmTypeInterventionsDescription
Control group (saline isotonic solution)Placebo comparatorDrug: saline isotonic solutionsaline isotonic solution
Curar (Atracurium) groupExperimentalDrug: Curare (Atracurium)Curar (Atracurium)
  • Curare (Atracurium) (Drug): Curare (Atracurium) versus saline isotonic solution for tracheal intubation
  • saline isotonic solution (Drug)

+Outcome measures

Primary outcomes

  • IDS score video-assessed as described by Adnet et al. Measurement will be made by 2 experts anesthesiologists for centralized reading [Assessment will be done at the end of the inclusions period (9 months)]: Number of IDS scores <2 are compared

Secondary outcomes

  • IDS score assesed by the intubator anesthesiologist [3 days post intubation]

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Elective Surgery Adult Patients
* no difficult intubation prediction

Exclusion Criteria:

+Locations (1)

FacilityCityCountryStatus
Chu de ReimsReimsFrance

My Notes